Natera (NTRA) Cash & Equivalents (2014 - 2026)
Natera's (NTRA) quarterly Cash & Equivalents came in at $1.1 billion in Q2 2026, up 10.0% on a YoY basis from $1.0 billion in Q2 2025, and little changed quarter-over-quarter from $1.1 billion in Q1 2026.
Analysis
Natera (NTRA) Cash & Equivalents (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Cash & Equivalents for 13 consecutive years, with $1.1 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash & Equivalents rose 10.0% year-over-year to $1.1 billion; the trailing twelve-month figure through Jun 2026 stood at $1.1 billion (up 10.0% YoY), and the FY2025 full-year result was $1.1 billion, up 13.81% from the prior year.
- Cash & Equivalents was little changed at $1.1 billion in Q2 2026 per NTRA's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Cash & Equivalents topped out at $1.1 billion in Q1 2026 and bottomed at $57.1 million in Q3 2022.
- Historically, Cash & Equivalents has averaged $700.5 million across 5 years, with a median of $805.3 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents plunged 39.93% in 2022, then jumped 1070.55% in 2023.
- Over 5 years, Cash & Equivalents stood at $466.1 million in 2022, then jumped by 37.76% to $642.1 million in 2023, then soared by 47.27% to $945.6 million in 2024, then advanced by 13.81% to $1.1 billion in 2025, then advanced by 2.22% to $1.1 billion in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 1.10 Bn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 626.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 141.80 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 1.05 Bn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 599.61 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 690.92 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 356.72 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 548.63 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 169.87 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 246.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Bn |
| Mar 31, 2026 | 1.10 Bn |
| Dec 31, 2025 | 1.08 Bn |
| Sep 30, 2025 | 1.04 Bn |
| Jun 30, 2025 | 1.00 Bn |
| Mar 31, 2025 | 973.77 Mn |
| Dec 31, 2024 | 945.59 Mn |
| Sep 30, 2024 | 892.84 Mn |
| Jun 30, 2024 | 796.80 Mn |
| Mar 31, 2024 | 813.82 Mn |
| Dec 31, 2023 | 642.10 Mn |
| Sep 30, 2023 | 668.71 Mn |
| Jun 30, 2023 | 381.11 Mn |
| Mar 31, 2023 | 403.15 Mn |
| Dec 31, 2022 | 466.09 Mn |
| Sep 30, 2022 | 57.13 Mn |
| Jun 30, 2022 | 91.38 Mn |
| Mar 31, 2022 | 158.53 Mn |
| Dec 31, 2021 | 84.61 Mn |
| Sep 30, 2021 | 95.10 Mn |